Pulmonary Vein Stenosis Symposium 2023

Needs Statement

The purpose of this conference is to further enhance the clinical knowledge of the pathophysiology of pulmonary vein stenosis. Furthermore, the modes of optimal diagnosis & treatment are incompletely defined Sharing of knowledge amongst leaders in the field is expected to improve care.

Educational Objectives

At the conclusion of the conference, participants should be able to:

• Recall the physiologic effects of pulmonary vein stenosis on pulmonary vein flow, intrapulmonary shunting, and disease progression
• Summarize the state-of-the-art catheter-based, surgical, and medical therapies used in treatment of pulmonary vein stenosis in terms of treatment and expected outcomes
• Outline the rationale and efficacy of team-based approach to treatment of pulmonary vein stenosis

Target Audience

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credits™.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.